ArticleBMC urology2023

Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab.

Soichi Matsumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.